Volker Möbus

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

Volker Möbus

Jul 21, 2024, 21:49 | Blog

Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…

Jul 20, 2024, 17:44 | Insight

Piotr Wysocki: Who should not get dose-dense adjuvant chemotherapy in breast cancer?

Piotr Wysocki recently posted on LinkedIn: "For many years, dose-dense adjuvant chemotherapy has been considered the…

Jul 20, 2024, 10:37 | Blog

Personalized Dose-Dense Adjuvant Chemotherapy for High-Risk Early breast cancer

Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…

Jul 19, 2024, 13:20 | Blog

Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer

Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…

All: 4 Posts: 1 - 100

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

'

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

'

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

'

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

'

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023